219 related articles for article (PubMed ID: 10885404)
21. Accuracy of Biopsy in Subtyping Periocular Basal Cell Carcinoma.
Sun MT; Wu A; Huilgol SC; Selva D
Ophthalmic Plast Reconstr Surg; 2015; 31(6):449-51. PubMed ID: 25794023
[TBL] [Abstract][Full Text] [Related]
22. A correlation of alpha-smooth muscle actin and invasion in micronodular basal cell carcinoma.
Christian MM; Moy RL; Wagner RF; Yen-Moore A
Dermatol Surg; 2001 May; 27(5):441-5. PubMed ID: 11359490
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical nuclear staining for p53, PCNA, Ki-67 and bcl-2 in different histologic variants of basal cell carcinoma.
Mateoiu C; Pirici A; Bogdan F
Rom J Morphol Embryol; 2011; 52(1 Suppl):315-9. PubMed ID: 21424069
[TBL] [Abstract][Full Text] [Related]
24. Interaction between bcl-2 and P53 in neoplastic progression of basal cell carcinoma of the head and neck.
Staibano S; Lo Muzio L; Pannone G; Scalvenzi M; Salvatore G; Errico ME; Fanali S; De Rosa G; Piattelli A
Anticancer Res; 2001; 21(6A):3757-64. PubMed ID: 11911244
[TBL] [Abstract][Full Text] [Related]
25. Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases.
Bianchi L; Orlandi A; Campione E; Angeloni C; Costanzo A; Spagnoli LG; Chimenti S
Br J Dermatol; 2004 Jul; 151(1):148-56. PubMed ID: 15270884
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.
Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559
[TBL] [Abstract][Full Text] [Related]
27. BAX protein is not expressed by basal cell carcinomas.
Rossen K; Karabulut Thorup A; Hou-Jensen K; Krag Jacobsen G
Br J Dermatol; 1998 Sep; 139(3):472-4. PubMed ID: 9767293
[TBL] [Abstract][Full Text] [Related]
28. Increased immunoreactivity of membrane type-1 matrix metalloproteinase (MT1-MMP) and β-catenin in high-risk basal cell carcinoma.
Oh ST; Kim HS; Yoo NJ; Lee WS; Cho BK; Reichrath J
Br J Dermatol; 2011 Dec; 165(6):1197-204. PubMed ID: 21729023
[TBL] [Abstract][Full Text] [Related]
29. Expression of beta-catenin in basal cell carcinoma.
El-Bahrawy M; El-Masry N; Alison M; Poulsom R; Fallowfield M
Br J Dermatol; 2003 May; 148(5):964-70. PubMed ID: 12786827
[TBL] [Abstract][Full Text] [Related]
30. Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions.
Boulinguez S; Grison-Tabone C; Lamant L; Valmary S; Viraben R; Bonnetblanc JM; Bédane C
Br J Dermatol; 2004 Sep; 151(3):623-6. PubMed ID: 15377349
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of incompletely excised basal cell carcinomas of the skin.
Rippey JJ; Rippey E
Med J Aust; 1997 Jun; 166(11):581-3. PubMed ID: 9201177
[TBL] [Abstract][Full Text] [Related]
32. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
Blixt E; Nelsen D; Stratman E
Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
[TBL] [Abstract][Full Text] [Related]
33. Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles.
Yu M; Zloty D; Cowan B; Shapiro J; Haegert A; Bell RH; Warshawski L; Carr N; McElwee KJ
J Invest Dermatol; 2008 Jul; 128(7):1797-805. PubMed ID: 18200053
[TBL] [Abstract][Full Text] [Related]
34. High discordance between punch biopsy and excision in establishing basal cell carcinoma subtype: analysis of 500 cases.
Wolberink EA; Pasch MC; Zeiler M; van Erp PE; Gerritsen MJ
J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):985-9. PubMed ID: 22759209
[TBL] [Abstract][Full Text] [Related]
35. Increased Marginal Stiffness Differentiates Infiltrative From Noninfiltrative Cutaneous Basal Cell Carcinomas in the Facial Area: A Prospective Study.
Alfageme F; Salgüero I; Nájera L; Suarez ML; Roustan G
J Ultrasound Med; 2019 Jul; 38(7):1841-1845. PubMed ID: 30467885
[TBL] [Abstract][Full Text] [Related]
36. Classifying distinct basal cell carcinoma subtype by means of dermatoscopy and reflectance confocal microscopy.
Longo C; Lallas A; Kyrgidis A; Rabinovitz H; Moscarella E; Ciardo S; Zalaudek I; Oliviero M; Losi A; Gonzalez S; Guitera P; Piana S; Argenziano G; Pellacani G
J Am Acad Dermatol; 2014 Oct; 71(4):716-724.e1. PubMed ID: 24928707
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of PHLDA1 (TDAG51) in basal cell carcinoma and trichoepithelioma.
Yeh I; McCalmont TH; LeBoit PE
Br J Dermatol; 2012 Nov; 167(5):1106-10. PubMed ID: 22958125
[TBL] [Abstract][Full Text] [Related]
38. Pigmented basal cell carcinoma: investigation of 70 cases.
Maloney ME; Jones DB; Sexton FM
J Am Acad Dermatol; 1992 Jul; 27(1):74-8. PubMed ID: 1377719
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: a pilot study.
Karahan N; Baspinar S; Bozkurt KK; Caloglu E; Ciris IM; Kapucuoglu N
Indian J Pathol Microbiol; 2011; 54(3):526-31. PubMed ID: 21934214
[TBL] [Abstract][Full Text] [Related]
40. Bcl-2 overexpression in basaloid proliferations overlying dermatofibromas and basal cell carcinomas.
Rossen K; Haerslev T; Hou-Jensen K; Jacobsen GK
APMIS; 1997 Jan; 105(1):35-40. PubMed ID: 9063499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
